Clinical

Dataset Information

0

JACCRO CC-11 study


ABSTRACT: Interventions: FOLFOXIRI+/-bevacizumab (To 12 courses), 5-FU+Levofolinate+/-bevacizumab (From 13 courses) given on day 1 every 2 weeks, until disease progression or unmanageable toxicity. bevacizumab 5mg/kg/bi-weekly Irinotecan 150mg/m2/bi-weekly Oxaliplatin 85mg/m2/bi-weekly Levofolinate 200mg/m2/bi-weekly 5-FU 2400mg/m2/bi-weekly Primary outcome(s): Response Rate Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose

DISEASE(S): Colorectal Cancer

PROVIDER: 2613998 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2633522 | ecrin-mdr-crc
| 2633714 | ecrin-mdr-crc
| 2630485 | ecrin-mdr-crc
| 2630804 | ecrin-mdr-crc
| 2630948 | ecrin-mdr-crc
| 2618714 | ecrin-mdr-crc
| 2622536 | ecrin-mdr-crc
| 2625196 | ecrin-mdr-crc
| 2623247 | ecrin-mdr-crc
| 2625142 | ecrin-mdr-crc